Paper36765754
Prostate Cancer-PET Imaging Update.
Jetty S and 5 others. Cancers (Basel), 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Prostate Cancer-PET Imaging Update. Papers, record 36765754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27526115 | The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. | Br J Pharmacol | 2016 | https://conductscience.org/library/papers/27526115 | PubMed |
| 2 | 35212559 | 18F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. | Radiol Imaging Cancer | 2022 | https://conductscience.org/library/papers/35212559 | PubMed |
| 3 | 35536144 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. | J Urol | 2022 | https://conductscience.org/library/papers/35536144 | PubMed |
| 4 | 20390384 | Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma. | Ann Nucl Med | 2010 | https://conductscience.org/library/papers/20390384 | PubMed |
| 5 | 25453051 | Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET. | J Nucl Med | 2014 | https://conductscience.org/library/papers/25453051 | PubMed |
| 6 | 29121144 | Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29121144 | PubMed |
| 7 | 26971788 | Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer. | Eur J Nucl Med Mol Imaging | 2016 | https://conductscience.org/library/papers/26971788 | PubMed |
| 8 | 35301240 | The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis. | J Nucl Med | 2022 | https://conductscience.org/library/papers/35301240 | PubMed |
| 9 | 26516369 | First-in-human uPAR PET: Imaging of Cancer Aggressiveness. | Theranostics | 2015 | https://conductscience.org/library/papers/26516369 | PubMed |
| 10 | 27749412 | Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. | Clin Nucl Med | 2017 | https://conductscience.org/library/papers/27749412 | PubMed |
| 11 | 25453047 | Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease. | J Nucl Med | 2014 | https://conductscience.org/library/papers/25453047 | PubMed |
| 12 | 24002508 | Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/24002508 | PubMed |
| 13 | 28800286 | Clinical PET Imaging in Prostate Cancer. | Radiographics | 2017 | https://conductscience.org/library/papers/28800286 | PubMed |
| 14 | 29320333 | Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls. | Radiographics | 2018 | https://conductscience.org/library/papers/29320333 | PubMed |
| 15 | 31068988 | Epidemiology of Prostate Cancer. | World J Oncol | 2019 | https://conductscience.org/library/papers/31068988 | PubMed |
| 16 | 31819826 | Axumin Positron Emission Tomography: Novel Agent for Prostate Cancer Biochemical Recurrence. | J Clin Imaging Sci | 2019 | https://conductscience.org/library/papers/31819826 | PubMed |
| 17 | 27694175 | Bombesin-Targeted PET of Prostate Cancer. | J Nucl Med | 2016 | https://conductscience.org/library/papers/27694175 | PubMed |
| 18 | 11113745 | Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers. | Urology | 2000 | https://conductscience.org/library/papers/11113745 | PubMed |
| 19 | 2449118 | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. | Anticancer Res | 1987 | https://conductscience.org/library/papers/2449118 | PubMed |
| 20 | 11920467 | Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. | Cancer | 2002 | https://conductscience.org/library/papers/11920467 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897296 | Rare prostate cancer histologies: detection, characteristics and treatment. | Nat Rev Urol | 2026 | https://conductscience.org/library/papers/42897296 | PubMed |
| 40752973 | Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types. | Diagn Interv Imaging | 2025 | https://conductscience.org/library/papers/40752973 | PubMed |
| 40430845 | The Development of Al18F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430845 | PubMed |
| 39776403 | Ultrasound radiomics model based on grayscale transrectal ultrasound-guided biopsy for diagnosing prostate cancer and predicting distant metastasis. | Int Urol Nephrol | 2025 | https://conductscience.org/library/papers/39776403 | PubMed |
| 39456584 | Advanced Imaging for Localized Prostate Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39456584 | PubMed |
| 39195294 | Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen. | Curr Oncol | 2024 | https://conductscience.org/library/papers/39195294 | PubMed |
| 39055460 | Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning. | Cureus | 2024 | https://conductscience.org/library/papers/39055460 | PubMed |
| 38500747 | Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer. | Am J Nucl Med Mol Imaging | 2024 | https://conductscience.org/library/papers/38500747 | PubMed |
| 37760506 | Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760506 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 | NCBI Gene |
| FOLH1 | 2346 | PubTator's text mining | https://conductscience.org/library/genes/2346 | NCBI Gene |
| GRPR | 2925 | PubTator's text mining | https://conductscience.org/library/genes/2925 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| PLAU | 5328 | PubTator's text mining | https://conductscience.org/library/genes/5328 | NCBI Gene |
| PLAUR | 5329 | PubTator's text mining | https://conductscience.org/library/genes/5329 | NCBI Gene |
| STEAP1 | 26872 | PubTator's text mining | https://conductscience.org/library/genes/26872 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765754
GET https://conductscience.org/api/papers/v1/36765754/references?page=2